About Zyga
Zyga is a Healthcare company based in Minnetonka (United States) founded in 2008, and was acquired by RTI Surgical in January 2018. Minimally invasive spinal surgery technology. Zyga has raised $42.75 million across 8 funding rounds from investors including SVB, Oxford Finance and Versant Ventures. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.
Company details
Zyga develops minimally invasive surgical technology for the lumbar spine. Has two products - Simmetry, a sacroiliac joint fusion system and Glyder, a facet restoration device to treat lumbar facet pain. Glyder is yet to be approved for commercial use.
- Headquarters Minnetonka, United States
- Stage Acquired
- SectorsHealthcare
- Website zyga.com
- Social LinkedIn
- Acquired by RTI Surgical (Jan 2018)
- Total Equity Funding$42.75M (USD)
in 8 rounds
- Latest Funding Round$15M (USD), Debt – Conventional
Nov 2015
- InvestorsSVB
& 7 more
- Acquired byRTI Surgical
(Jan 2018)
Funding Insights of Zyga
Zyga has successfully raised a total of $42.75M across 8 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $15 million completed in November 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $42.75M
- Total Rounds 8
- Last Round Debt – Conventional — $15M
- First Round $5.75M
(Oct 2009)
- Investors Count 7
All 8 funding rounds of Zyga with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | $5M | Series C | – | Versant Ventures, Domain Associates | – |
| Nov 2015 | $15M | Debt – Conventional | – | – | |
| Dec 2014 | $2M | Series C | – | – | – |
| Sep 2014 | $8M | Debt – Conventional | – | – | |
| Dec 2013 | $10M | Series C | – | – | – |
| May 2012 | $15M | Series C | – | Versant Ventures, Domain Associates | – |
| Jun 2011 | $5M | Series B | – | – | – |
| Oct 2009 | $5.75M | Series A | – | – | – |
8 investors in total: 8 institutional.
Investors in Zyga
Zyga has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Oxford Finance and Versant Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | versantventures.com | |||
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Capital and strategic direction are provided to life science companies. | mbventures.com | Memphis, United States | ||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
US venture capital investments are made across all stages. | splitrock.com | Eden Prairie, United States | ||
| bridgebankcapital.co.uk | ||||
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Develops innovative technologies for spinal and orthopedic implants and instruments. | 1992 | rtix.com | Alachua, United States |
Investor details for Zyga
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Zyga
4 dated milestones of Zyga across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Zyga is founded.
- Funding First funding round of $5.8M.
- Funding Latest funding round, Debt – Conventional, of $15.0M.
- Exit Acquired by RTI Surgical.
Competitors of Zyga
Zyga has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| atecspine.com | 1990 | San Diego, United States | 839 | Treatment solutions for spine disorders are developed. | ||
| vertosmed.com | 2005 | Aliso Viejo, United States | $177.75M | 140 | Minimally invasive treatments for lumbar spinal stenosis are developed. |
Detailed competitors of Zyga
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Zyga (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zyga
Complete news archive for Zyga
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zyga
Zyga was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Zyga is headquartered in Minnetonka, United States. It is registered at Minnetonka, Minnesota, United States.
Zyga is a funded company, having raised a total of $42.75M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5.75M, raised on Oct 2009.
Zyga develops minimally invasive surgical technology for the lumbar spine. Has two products - Simmetry, a sacroiliac joint fusion system and Glyder, a facet restoration device to treat lumbar facet pain. Glyder is yet to be approved for commercial use.
Zyga's top competitors include Nevro, ATEC Spine and Vertos Medical.
Zyga has 8 investors. Key investors include SVB, Oxford Finance, Versant Ventures, Domain Associates, and MB Venture Partners.
Yes. Zyga was acquired by RTI Surgical in January 2018.